Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old

We compared efavirenz pharmacokinetic (PK) parameters in children with tuberculosis (TB)/human immunodeficiency virus (HIV) coinfection on and off first-line antituberculosis therapy to that in HIV-infected children. Children 3 to 14 years old with HIV infection, with and without TB, were treated wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Kwara, Awewura, Yang, Hongmei, Antwi, Sampson, Enimil, Anthony, Gillani, Fizza S., Dompreh, Albert, Ortsin, Antoinette, Opoku, Theresa, Bosomtwe, Dennis, Sarfo, Anima, Wiesner, Lubbe, Norman, Jennifer, Alghamdi, Wael A., Langaee, Taimour, Peloquin, Charles A., Court, Michael H., Greenblatt, David J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325194/
https://ncbi.nlm.nih.gov/pubmed/30397066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01657-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados